Skip to main content

Table 3 Dominant drug type and transition of drug type over 3 months intervals stratified for women and men

From: Sex-specific differences and how to handle them in early psoriatic arthritis

Timepoint

Previous DMARD use

DMARD use

Women

Men

Methotrexate

Steroids

cs-DMARDs

b-DMARDs

no DMARD

Methotrexate

Steroids

Cs-DMARDs

b-DMARDs

None

Baseline

 

54%

1%

12%

2%

32%

56%

2%

6%

4%

33%

T3

Methotrexate

77%

1%

6%

6%

10%

88%

 

4%

1%

7%

Steroids

50%

50%

   

40%

40%

20%

  

cs-DMARDs

17%

 

63%

 

20%

18%

 

65%

 

18%

b-DMARDs

   

100%

    

91%

9%

None

13%

 

4%

 

84%

11%

 

1%

1%

87%

T6

Methotrexate

88%

 

5%

3%

4%

82%

1%

2%

6%

9%

Steroids

50%

50%

    

100%

   

cs-DMARDs

13%

 

81%

 

6%

5%

 

79%

5%

11%

b-DMARDs

13%

  

73%

13%

  

7%

79%

14%

None

10%

 

5%

3%

81%

9%

1%

1%

1%

87%

T9

Methotrexate

69%

 

12%

6%

13%

78%

 

5%

6%

12%

Steroids

 

100%

   

25%

25%

25%

 

25%

cs-DMARDs

11%

 

78%

 

11%

  

72%

11%

17%

b-DMARDs

22%

  

72%

6%

5%

  

79%

16%

None

7%

 

2%

5%

87%

4%

 

3%

 

93%

T12

Methotrexate

79%

 

3%

7%

11%

83%

1%

6%

3%

7%

Steroids

  

100%

   

100%

   

cs-DMARDs

15%

 

56%

15%

15%

6%

 

67%

11%

17%

b-DMARDs

5%

  

86%

10%

4%

  

85%

12%

None

13%

 

6%

1%

80%

12%

1%

5%

1%

80%

  1. *cs-DMARD, conventional synthetic DMARDS excluding methotrexate